Law360, New York (January 10, 2007, 12:00 AM ET) -- On January 9, 2007, the Supreme Court issued its highly-anticipated decision in MedImmune, Inc. v. Genentech, Inc., No. 05-608 (Scalia, J.), holding that a patent licensee may bring a declaratory judgment action seeking a decision that the licensed patent is invalid or not infringed even if the licensee is continuing to pay royalties under the license. Obviously, this decision will have a significant impact on licensor/licensee relationships and on the settlement of patent disputes.
Lost in most of the discussion of MedImmune, however, is the Supreme...
Supreme Court Backhands Key Federal Circuit Test
To view the full article, take a free trial now.
